<PAGE>
Exhibit 1.1
12,800,000 SHARES
AGCO CORPORATION
COMMON STOCK, $0.01 PAR VALUE
UNDERWRITING AGREEMENT
April 1, 2004
<PAGE>
April 1, 2004
Morgan Stanley & Co. Incorporated
Goldman, Sachs & Co.
1585 Broadway
85 Broad Street
New York, New York 10036
New York, New York 10004
Dear Sirs and Mesdames:
AGCO Corporation, a Delaware corporation (the "COMPANY"), proposes
to
issue and sell to the several Underwriters
named in Schedule I hereto (the
"UNDERWRITERS") 12,800,000 shares of its
common stock, $0.01 par value (the
"FIRM SHARES"). The Company also proposes
to issue and sell to the several
Underwriters not more than an additional
1,920,000 shares of its common stock,
$0.01 par value (the "ADDITIONAL SHARES"),
if and to the extent that you, as
Managers of the offering, shall have
determined to exercise, on behalf of the
Underwriters, the right to purchase such
shares of common stock granted to the
Underwriters in Section 2 hereof. The Firm
Shares and the Additional Shares are
hereinafter collectively referred to as the
"SHARES." The shares of common
stock, $0.01 par value, of the Company are
hereinafter referred to as the
"COMMON STOCK."
The Company has filed with the Securities and Exchange Commission
(the
"COMMISSION") a registration statement,
including a prospectus, relating to the
Shares, and such registration statement has
been declared effective by the
Commission under the Securities Act of
1933, as amended the ("SECURITIES ACT").
The registration statement as amended at
the time it became effective, including
the information (if any) deemed to be part
of the registration statement at the
time of effectiveness pursuant to Rule 430A
under the Securities Act, is
hereinafter referred to as the
"REGISTRATION STATEMENT"; the prospectus in the
form first used to confirm sales of Shares
(including any related prospectus
supplement) is hereinafter referred to as
the "PROSPECTUS." If the Company has
filed an abbreviated registration statement
to register additional shares of
Common Stock pursuant to Rule 462(b) under
the Securities Act (the "RULE 462
REGISTRATION STATEMENT"), then any
reference herein to the term "REGISTRATION
STATEMENT" shall be deemed to include such
Rule 462 Registration Statement
(including, in the case of all references
to the Registration Statement and the
Prospectus, documents incorporated therein
by reference).
1. Representations and Warranties. The Company represents and
warrants
to and agrees with each of the Underwriters
that:
<PAGE>
(a) The Registration Statement has become effective under the
Securities Act; no stop order suspending the effectiveness of
the
Registration Statement is in effect, and, to the knowledge of
the
Company, no proceedings for such purpose are pending before or
threatened by the Commission.
(b) (i) Each document, if any, filed or to be filed pursuant
to the Securities Exchange Act of 1934, as amended (the
"EXCHANGE
ACT"), and incorporated by reference in the Prospectus complied or
will
comply when so filed in all material respects with the Exchange Act
and
the applicable rules and regulations of the Commission thereunder,
(ii)
the Registration Statement, when it became effective, did not
contain
and, as amended or supplemented, if applicable, will not contain
any
untrue statement of a material fact or omit to state a material
fact
required to be stated therein or necessary to make the
statements
therein not misleading, (iii) the Registration Statement and
the
Prospectus comply and, as amended or supplemented, if applicable,
will
comply in all
material respects with the Securities Act and the
applicable rules and regulations of the Commission thereunder and
(iv)
the Prospectus does not contain and, as amended or supplemented,
if
applicable, will not contain any untrue statement of a material
fact or
omit to state a material fact necessary to make the statements
therein,
in the light of the circumstances under which they were made,
not
misleading, except that the representations and warranties set
forth in
this paragraph do not apply to statements or omissions in the
Registration Statement or the Prospectus based upon information
relating to any Underwriter furnished to the Company in writing by
such
Underwriter through you expressly for use therein.
(c) The Company has been duly incorporated, is validly
existing as a corporation in good standing under the laws of
the
jurisdiction of its incorporation, has the corporate power and
authority to own its property and to conduct its business as
described
in the Prospectus and is duly qualified to transact business and is
in
good standing (to the extent that good standing is a concept
recognized
by such jurisdiction) in each jurisdiction in which the conduct of
its
business or its ownership or leasing of property requires such
qualification, except to the extent that the failure to be so
qualified
or be in good standing would not have a material adverse effect on
the
Company and its subsidiaries, taken as a whole.
(d) Each subsidiary of the Company has been duly incorporated,
is validly existing as a corporation in good standing under the
laws of
the jurisdiction of its incorporation, has the corporate power
and
authority to own its property and to conduct its business as
described
in the Prospectus and is duly qualified to transact business and is
in
good standing in each jurisdiction in which the conduct of its
business
or its ownership or leasing of property requires such
qualification,
except to the extent that the failure
2
<PAGE>
to be so qualified or be in good standing would not have a
material
adverse effect on the Company and its subsidiaries, taken as a
whole;
all of the issued shares of capital stock of each subsidiary of
the
Company have been duly
and validly authorized and issued, are fully
paid and non-assessable and are owned directly by the Company, free
and
clear of all liens, encumbrances, equities or claims.
(e) This Agreement has been duly authorized, executed and
delivered by the Company.
(f) The authorized capital stock of the Company conforms as to
legal matters to the description thereof contained in the
Prospectus.
(g) The shares of Common Stock outstanding prior to the
issuance of the Shares have been duly authorized and are
validly
issued, fully paid and non-assessable, and there are no authorized
or
outstanding options, warrants or other rights to purchase, or
equity or
debt securities convertible into or exchangeable or exercisable
for,
any shares of Common Stock except as described in the
Prospectus.
(h) The Shares have been duly authorized and, when issued and
delivered in accordance with the terms of this Agreement, will
be
validly issued, fully paid and non-assessable, and the issuance of
such
Shares will not be subject to any preemptive or similar rights.
(i) The Shares have been approved for listing on the New York
Stock Exchange, subject only to official notice of issuance.
(j) The execution and delivery by the Company of, and the
performance by the Company of its obligations under, this
Agreement
will not contravene any provision of applicable law or the
certificate
of incorporation or by-laws of the Company or any agreement or
other
instrument binding upon the Company or any of its subsidiaries that
is
material to the Company and its subsidiaries, taken as a whole, or
any
judgment, order or decree of any governmental body, agency or
court
having jurisdiction over the Company or any subsidiary, or result
in
the creation or imposition of any lien, charge or encumbrance upon
any
assets or property of the Company or any of its subsidiaries, and
no
consent, approval, authorization or order of, or qualification
or
filing with, any governmental body or agency, any lender or any
other
person is required for the performance by the Company of its
obligations under this Agreement, except such consents received
prior
to the date hereof and such as may be required by the securities
or
Blue Sky laws of the various states or international jurisdictions
in
connection with the offer and sale of the Shares.
3
<PAGE>
(k) The consolidated financial statements of the Company and
its subsidiaries, together with related notes and schedules, as
set
forth in the Registration Statement and the Prospectus present
fairly,
in all material respects, the consolidated financial position,
the
results of operations and cash flows of the Company and the
Subsidiaries, on a consolidated basis, as of the indicated dates
and
for the indicated periods. Such financial statements comply as to
form
in all material respects with the rules of the Commission with
respect
thereto and have been prepared in accordance with generally
accepted
accounting principles in the United States ("GAAP"),
consistently
applied throughout the periods involved, and all adjustments
necessary
for a fair presentation of results for such periods have been made;
any
schedules included in the Registration Statement present fairly
the
information required to be stated therein. No other financial
statements or supporting schedules are required to be included in
the
Registration Statement. The pro forma financial information and
related
notes thereto included in the Registration Statement and the
Prospectus
present fairly the
information shown therein, have been prepared in
accordance with the Securities Act and the rules of the Commission
with
respect to pro forma financial information, have been prepared on
a
basis consistent with the historical financial statements of
the
Company and have been compiled on the pro forma bases described
therein, and (A) the assumptions underlying the pro forma
adjustments
are reasonable, (B) such adjustments are appropriate to give effect
to
the transactions or circumstances referred to therein and have
been
properly applied to the historical amounts in the compilation of
such
statements and (C) such statements fairly present the pro forma
results
of operations and information purported to be shown therein for
the
respective periods therein specified based on the assumptions
identified therein. Except (X) as disclosed in the Prospectus, (Y)
as
reflected in the Company's audited balance sheet at December 31,
2003
or liabilities described in any notes thereto (or liabilities for
which
neither accrual nor footnote disclosure is required pursuant to
GAAP)
or (Z) for liabilities incurred in the ordinary course of
business
since December 31, 2003 consistent with past practice, neither
the
Company nor any subsidiary has any material liabilities or
obligations
of any nature. Except as set forth in the Prospectus, neither
the
Company nor any subsidiary has engaged in or effected any
transaction
or arrangement that would constitute an "off-balance sheet
arrangement"
(as defined in Item 303 of Regulation S-K of the Commission).
The
financial information included in the Prospectus included under
the
captions "Summary--AGCO Corporation Summary Historical Financial
Data,"
"Summary - Summary Unaudited Pro Forma Combined Financial
Data,"
"Capitalization," "Selected Consolidated Financial Data" and
"Management's Discussion and Analysis of Financial Condition
and
Results of Operations," (and any amendment or supplement
thereto)
present fairly in accordance with GAAP the information shown
therein
(except for non-GAAP financial measures and ratios which have
been
presented in compliance with Regulation G) and have been compiled
on a
4
<PAGE>
basis consistent with that of the audited and unaudited
financial
statements from which they were derived.
(l) Since the respective dates as of which information is
given in the Prospectus and exclusive of any amendments or
supplements
thereto subsequent to the date of this Agreement, (i) there has
not
occurred any material adverse change, or any development that
might
reasonably be expected to result in a prospective material
adverse
change, in the condition, financial or otherwise, or in the
earnings,
business or operations of the Company and its subsidiaries, taken
as a
whole; (ii) there have been no transactions entered into by the
Company
or any of its subsidiaries, other than those in the ordinary course
of
business, which are material to the Company and its subsidiaries,
taken
as a whole, and (iii) except for regular dividends on the common
stock
of the Company in amounts per share that are consistent with
past
practice, there has been no dividend or distribution of any
kind
declared, paid or made by the Company on any class of its
capital
stock.
(m) There are no legal or governmental proceedings pending or,
to the knowledge of
the Company, threatened, to which the Company or
any of its subsidiaries is a party or to which any of the
properties of
the Company or any of its subsidiaries is subject other than
proceedings accurately described in all material respects in
the
Registration Statement or the Prospectus and proceedings that would
not
have a material adverse effect on the Company and its
subsidiaries,
taken as a whole, or any statutes or regulations that are required
to
be described in the Registration Statement or the Prospectus or to
be
filed as exhibits to the Registration Statement that are not
described
or filed as required.
(n) Each preliminary prospectus filed as part of the
registration statement as originally filed or as part of any
amendment
thereto, or filed pursuant to Rule 424 under the Securities
Act,
complied when so filed in all material respects with the Securities
Act
and the applicable rules and regulations of the Commission
thereunder.
(o) The Company is not, and after giving effect to the
offering and sale of the Shares and the application of the
proceeds
thereof as described in the Prospectus will not be, required to
register as an "investment company" as such term is defined in
the
Investment Company Act of 1940, as amended.
(p) The Company and its subsidiaries (i) are in compliance
with any and all applicable foreign, federal, state and local laws
and
regulations relating to the protection of human health and safety,
the
environment or hazardous or toxic substances or wastes, pollutants
or
contaminants ("ENVIRONMENTAL LAWS"), (ii) have received all
permits,
licenses or other approvals required of them under applicable
Environmental Laws to
5
<PAGE>
conduct their respective businesses and (iii) are in compliance
with
all terms and conditions of any such permit, license or
approval,
except where such noncompliance with Environmental Laws, failure
to
receive required permits, licenses or other approvals or failure
to
comply with the terms and conditions of such permits, licenses
or
approvals would not, singly or in the aggregate, have a
material
adverse effect on the Company and its subsidiaries, taken as a
whole.
(q) To the Company's knowledge, KPMG LLP ("KPMG"), independent
auditors who have certified certain of the financial statements of
the
Company and its subsidiaries contained in the Prospectus and
the
Registration Statement, are and were during the periods covered
by
their reports included in the Prospectus and the Registration
Statement
independent public accountants within the meaning of the
Securities
Act, Regulation S-X of the Commission and Rule 101 of the Code
of
Professional Ethics of the American Institute of Certified
Public
Accountants. KPMG (i) based solely on representations made by KPMG,
is,
to the Company's knowledge, a registered public accounting firm
(as
defined in Section 2(a)(12) of the Sarbanes-Oxley Act of 2002)
("SOX")
and (ii) is, with respect to the Company, in compliance with
subsections (g) through (l) of Section 10A of the Exchange Act.
(r) The Company and each of its subsidiaries maintain
disclosure controls and procedures (as defined in Rule 13a-15(e) of
the
Commission) that are designed to ensure that information required
to be
disclosed by the Company in the reports it files or submits under
the
Exchange Act is recorded, processed, summarized and reported within
the
time periods specified in the Commission's rules and forms.
(s) The Company and each of its subsidiaries maintain internal
control over financial reporting (as defined in Rule 13a-15(f) of
the
Commission) sufficient to provide reasonable assurance regarding
the
(A) reliability of financial reporting and the preparation of
financial
statements for external purposes in accordance with GAAP, (B)
maintenance of records that in reasonable detail accurately and
fairly
reflect transactions and dispositions of the assets of the Company
and
its subsidiaries, (C) recording of transactions as necessary to
permit
preparation of financial statements in accordance with GAAP and
that
receipts and expenditures of the Company and its subsidiaries are
being
made only in accordance with authorizations of management and
directors
of the Company or the applicable subsidiary, and (D) prevention
or
timely detection of unauthorized acquisition, use or disposition of
the
Company's or its subsidiaries' assets that could have a material
effect
on the financial statements.
(t) The Company's management evaluates, with the participation
of the Company's principal executive and principal financial
6
<PAGE>
officers, or persons
performing similar functions, (A) the
effectiveness of the Company's and its subsidiaries' disclosure
controls and procedures as of the end of each fiscal quarter, (B)
the
Company's and its subsidiaries' internal control over financial
reporting as of the end of each fiscal year, and (C) any change in
the
Company's or its subsidiaries' internal control over financial
reporting that occurred during each of the Company's fiscal
quarters
that has materially affected, or is reasonably likely to
materially
affect, the Company's or any subsidiaries' internal control
over
financial reporting.
(u) Except as disclosed in the Prospectus, the Company has
not, since July 30, 2002, extended or maintained credit, arranged
for
the extension of credit, or renewed an extension of credit, in the
form
of a personal loan to or for any director or executive officer of
the
Company; and any such credit that was outstanding on July 30, 2002
or
that is currently outstanding was in place on or before July 30,
2002,
and there has been no material modification of any term of such
credit
or any renewal or such credit on or after July 30, 2002.
(v) The Company is in compliance with all U.S. laws, and,
specifically, has not directly or indirectly used any proceeds of
any
debt or equity offerings, and has not permitted any person or
entity to
which the Company made such proceeds available to use them, to
finance
the activities of any person or entity that is subject to
sanctions
under, or otherwise in a manner that places the Company, any
affiliate
thereof or any director, officer, employee or agent of any of
the
foregoing in violation of any law, regulation, order or license
relating to any program administered by the Office of Foreign
Assets
Control ("OFAC") of the United States Department of the
Treasury,
including, without limitation, any program the regulations of which
are
codified in Chapter 5 of Subtitle B of Title 31 of the Code of
Federal
Regulations.
2. Agreements to Sell and Purchase. The Company hereby agrees to
sell
to the several Underwriters, and each
Underwriter, upon the basis of the
representations and warranties herein
contained, but subject to the conditions
hereinafter stated, agrees, severally and
not jointly, to purchase from the
Company the respective numbers of Firm
Shares set forth in Schedule I hereto
opposite its name at $20.39 a share (the
"PURCHASE PRICE").
On the basis of the representations and warranties contained in
this
Agreement, and subject to its terms and
conditions, the Company agrees to sell
to the Underwriters the Additional Shares,
and the Underwriters shall have the
right to purchase, severally and not
jointly, up to 1,920,000 Additional Shares
at the Purchase Price. You may exercise
this right on behalf of the Underwriters
in whole or from time to time in part by
giving written notice of each election
to exercise the option not later than 30
days after the date of this Agreement.
Any exercise notice shall specify the
number of Additional Shares to be
purchased by
7
<PAGE>
the Underwriters and the date on which such
shares are to be purchased. Each
purchase date must be at least one business
day after the written notice is
given and may not be earlier than the
closing date for the Firm Shares nor later
than ten business days after the date of
such notice. Additional Shares may be
purchased as provided in Section 4 hereof
solely for the purpose of covering
over-allotments made in connection with the
offering of the Firm Shares. On each
day, if any, that Additional Shares are to
be purchased, each Underwriter
agrees, severally and not jointly, to
purchase the number of Additional Shares
(subject to such adjustments to eliminate
fractional shares as you may
determine) that bears the same proportion
to the total number of Additional
Shares to be purchased on such date as the
number of Firm Shares set forth in
Schedule I hereto opposite the name of such
Underwriter bears to the total
number of Firm Shares.
The Company hereby agrees that, without the prior written consent
of
Morgan Stanley & Co. Incorporated and
Goldman, Sachs & Co. on behalf of the
Underwriters, it will not, during the
period ending 90 days after the date of
the Prospectus, (i) offer, pledge, sell,
contract to sell, sell any option or
contract to purchase, purchase any option
or contract to sell, grant any option,
right or warrant to purchase, lend, or
otherwise transfer or dispose of,
directly or indirectly, any shares of
Common Stock or any sec